(Q40060739)

17 September 2017

The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus (English)

1 reference

17 September 2017

0 references

1 reference

4

1 reference

17 September 2017

Helmut Kutz

1

1 reference

17 September 2017

Gilbert Reisbach

series ordinal

2

1 reference

17 September 2017

Ute Schultheiss

series ordinal

3

1 reference

17 September 2017

language of work or name

English

0 references

publication date

29 October 2007

1 reference

17 September 2017

1 reference

17 September 2017

371

1 reference

17 September 2017

2

1 reference

17 September 2017

246-256

1 reference

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Selective repression of low-density lipoprotein receptor expression by SP600125: coupling of histone H3-Ser10 phosphorylation and Sp1 occupancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Signal transduction by the Epstein-Barr virus oncogene latent membrane protein 1 (LMP1)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

LMP1 signal transduction differs substantially from TNF receptor 1 signaling in the molecular functions of TRADD and TRAF2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

B cells under influence: transformation of B cells by Epstein–Barr virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

The mammalian Jun proteins: redundancy and specificity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Plat-E: an efficient and stable system for transient packaging of retroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

AML1-ETO inhibits maturation of multiple lymphohematopoietic lineages and induces myeloblast transformation in synergy with ICSBP deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

AP-1 as a regulator of cell life and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus: exploiting the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

7 January 2021

Jun, the oncoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Elucidation of the c-Jun N-terminal kinase pathway mediated by Estein-Barr virus-encoded latent membrane protein 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

Epstein-Barr virus: 40 years on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2007.09.044

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2007.09.044

1 reference

17 September 2017

1 reference